JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Apellis Pharmaceuticals (NASDAQ:APLS) Stock
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its price target lifted by research analysts at JPMorgan Chase & Co. from $50.00 to $54.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would suggest a […]
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its price target lifted by research analysts at JPMorgan Chase & Co. from $50.00 to $54.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would suggest a […]
